Feature | May 30, 2013

Houston-based researchers document the value of 3-D mammography as a breast cancer screening technology.

First Large-Scale U.S. Study Validates the Benefits of 3-D Mammography

May 30, 2013 — A recently published clinical study conducted at TOPS Comprehensive Breast Center in Houston, Texas, demonstrates that 3-D mammography (breast tomosynthesis) significantly reduces unnecessary recalls while simultaneously increasing cancer detection.

The study, "Implementation of Breast Tomosynthesis in a Routine Screening Practice: An Observational Study," was led by Stephen L. Rose, M.D., and published in the June issue of the American Journal of Roentgenology (AJR). 

The study examined the use of Hologic's 3-D mammography in conjunction with 2-D mammography. The researchers found that 3-D mammography:

  • Reduced recall rates by 37 percent;
  • Increased the detection of cancers by over 30 percent; and
  • Increased the detection of invasive cancers by more than 50 percent.

 

Instead of viewing all the complexities of the breast tissue in a flat image as with a traditional mammogram, 3-D mammography uses multiple low-dose images to create a 3-D view of the breast. 3-D mammography allows the doctor to examine 3-D breast images layer-by-layer.

The 2010 through 2012 study population included 13,856 women who received conventional 2-D mammography screening exams prior to the introduction of Hologic's 3-D mammography technology (breast tomosynthesis) and 9,499 women who received a 3-D mammography screening exam. Images in both time periods were interpreted by six radiologists with an average 12 years of reading experience.  

"We are finding cancerous breast tumors as small as two to three millimeters," Rose said. "We are finding cancer earlier and this will allow us to reduce the amount of treatment patients need."  Rose projects that as 3-D mammography becomes the standard breast cancer screening tool the size of tumors found will get smaller, and accuracy of deciding between benign and cancerous tumors will improve.

    For more information: www.breasttomo.com

 


Related Content

News | Mammography

April 29, 2025 — iCAD, a global provider of clinically proven AI-powered cancer detection solutions, has announced a ...

Time April 29, 2025
arrow
News | Mammography

April 24, 2025 — GE HealthCare will feature its latest advancements in diagnostic accuracy and patient-centered breast ...

Time April 24, 2025
arrow
News | Artificial Intelligence

March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...

Time March 10, 2025
arrow
News | Artificial Intelligence

Feb. 19, 2025 — SimonMed Imaging and HeartLung Technologies have signed a strategic partnership to offer HeartLung's AI ...

Time March 04, 2025
arrow
News | Ultrasound Imaging

Jan. 28, 2025 — GE HealthCare recently announced it has received 510(k) clearance from the United States Food and Drug ...

Time January 29, 2025
arrow
News | Breast Imaging

Jan. 8, 2025 — ScreenPoint Medical has acquiredf Biomediq A/S, a research-based company focused on the research ...

Time January 10, 2025
arrow
News | Breast Imaging

Dec.11, 2024 — iCAD, Inc., a provider of clinically proven AI-powered cancer detection solutions, recently announced ...

Time December 18, 2024
arrow
News | Mammography

Dec. 5, 2024 — At RSNA 2024, Lunit and Volpara Health announced their unified vision, focusing on a comprehensive ...

Time December 05, 2024
arrow
News | Mammography

Nov. 26, 2024 — GE HealthCare has introduced the Pristina Via* mammography system designed to enhance the screening ...

Time December 02, 2024
arrow
News | Artificial Intelligence

Dec. 2, 2024 — Lunit recently unveiled follow-up findings from the ScreenTrustCAD trial. This study, conducted at Capio ...

Time December 02, 2024
arrow
Subscribe Now